[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]

AFRO-NETS> Understanding TRIPS (Patents & Access to Drugs)


  • Subject: AFRO-NETS> Understanding TRIPS (Patents & Access to Drugs)
  • From: A Odutola <chpss_abo@yahoo.com>
  • Date: Wed, 19 Feb 2003 00:51:11 -0500 (EST)




Understanding TRIPS (Patents & Access to Drugs)
-----------------------------------------------

Understanding TRIPS (Patents & Access to Drugs) - Pharmaceutical
politics 101
http://www.guardian.co.uk/aids/story/0,7369,897306,00.html

The drug industry needs Capitol Hill on its side

by Sarah Boseley
Tuesday February 18, 2003
The Guardian


Profits 2001
------------
Pfizer Inc US$ 7,788m
Glaxo SmithKline US$ 7,325m
Merck & Co US$ 7,282m
Bristol-Myers Squibb US$ 5,242m
Abbott Laboratories US$ 1,550m


Political donations, US election cycle 2002
-------------------------------------------
Pfizer Inc US$ 1.67m
Bristol-Myers Squibb US$ 1.57m
Glaxo SmithKline US$ 1.14m
Abbott Laboratories US$ 0.64m
Merck & Co US$ 0.57m
Industry total US$ 19.07m

* The vast majority of donations were to the Republicans, from 77%
(Merck & Co) to 93% (Abbott Laboratories). Across the industry 95% of
donations go to the Republicans.

Reproduced as 'fair use'. Guardian Unlimited ©
Guardian Newspapers Limited 2003

--
A. Odutola
mailto:chpss_abo@yahoo.com

--
To send a message to AFRO-NETS, write to: afro-nets@usa.healthnet.org
To subscribe or unsubscribe, write to: majordomo@usa.healthnet.org
in the body of the message type: subscribe afro-nets OR unsubscribe afro-nets
To contact a person, send a message to: afro-nets-help@usa.healthnet.org
Information and archives: http://www.afronets.org